Chia-Chung Hou

Title: Chia-Chung Hou: Innovator in Cancer Treatment and Insect Immunity

Introduction

Chia-Chung Hou is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the fields of cancer treatment and insect immunity. With a total of 2 patents, his work reflects a commitment to advancing medical science and biotechnology.

Latest Patents

Chia-Chung Hou's latest patents include innovative methods for addressing critical health challenges. One of his notable inventions is a composition and method for treating drug-resistant cancer. This invention provides a combination of Temozolomide (TMZ) and an isoform-selective HDAC8 inhibitor, such as BMX, to enhance the cytotoxic effect of TMZ by downregulating the β-catenin/c-Myc/SOX2 signaling pathway and upregulating WT-p53 mediated MGMT inhibition. Another significant patent focuses on enhancing the immunity of insects, particularly bees. This method involves administering an effective amount of a composition designed to boost the immune response of these insects.

Career Highlights

Throughout his career, Chia-Chung Hou has worked with several notable companies, including Novelwise Pharmaceutical Corporation and Naturewise Biotech and Medicals Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas.

Collaborations

Chia-Chung Hou has collaborated with esteemed colleagues such as Chung-Yang Huang and Yu-Cheng Kuo. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Chia-Chung Hou stands out as an influential inventor whose work in cancer treatment and insect immunity showcases his dedication to innovation. His contributions are paving the way for future advancements in these critical areas of research.